Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Complete molecular response"'
Autor:
Radhika Takiar, Charles E. Foucar, Anthony J. Perissinotti, Bernard L. Marini, Lydia Benitez-Colon, Patrick W. Burke, Dale L. Bixby
Publikováno v:
Leukemia Research Reports, Vol 18, Iss , Pp 100352- (2022)
Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL) has been associated with a worse prognosis compared to Ph negative ALL. Tyrosine kinase inhibitor (TKI) therapy has led to an improvement in response rates and survival, thus b
Externí odkaz:
https://doaj.org/article/e096d88ed8ad497e997eb66c0f651fe3
Publikováno v:
Clinical Management Issues, Vol 5, Iss 5S, Pp 21-25 (2015)
In 1997, a forty-three years old woman was diagnosed with CML and treated with alfa-Interferon, achieving complete haematological response (CHR). Three years later, patient was switched to hydroxiurea due to thyroid toxicity. For logistic reasons, th
Externí odkaz:
https://doaj.org/article/566c97955e024e39ad26045bf2328822
Autor:
Qiaoling Ma, Aiming Pang, Yi He, Guixin Zhang, Weihua Zhai, Jialin Wei, Mengnan Lyu, R L Zhang, Erlie Jiang, Mingzhe Han, Sizhou Feng, Yong Huang, Donglin Yang
Publikováno v:
Hematology. 26:65-74
Objectives: To analyze the outcomes of patients who received autologous stem cell transplantation (auto-SCT), matched sibling donor stem cell transplantation (MSD-SCT) and haploidentical stem cell ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::144a82a27a48cc184b061afe04c80c6c
https://doi.org/10.1080/16078454.2020.1868783
https://doi.org/10.1080/16078454.2020.1868783
Publikováno v:
eJHaem. 1:309-311
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25b40353d0d221f21228af97e9ac6212
https://doi.org/10.1002/jha2.21
https://doi.org/10.1002/jha2.21
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M N, Lyu, E L, Jiang, Y, He, D L, Yang, Q L, Ma, A M, Pang, W H, Zhai, J L, Wei, Y, Huang, G X, Zhang, R L, Zhang, S Z, Feng, M Z, Han
Publikováno v:
Chinese Journal of Hematology
目的 比较自体造血干细胞移植（auto-HSCT）和同胞全相合造血干细胞移植（MSD-HSCT）治疗费城染色体阳性急性淋巴细胞白血病（Ph+ ALL）的疗效，为患者移植方式的选择提供依据。 方法 回顾性
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d0582f5e022d9d3b65717ba406d69b9a
https://pubmed.ncbi.nlm.nih.gov/32536133
https://pubmed.ncbi.nlm.nih.gov/32536133
Autor:
Muhammad Waheed Tahir, Fatima Khalid, Syed Ali Raza, Umera Saleem, Muhammad Khurrum Islam, Talha Hafeez
Publikováno v:
Cureus
Introduction: The hallmark of chronic myeloid leukemia (CML) is the development of the fusion gene, BCR-ABL which has unopposed tyrosine kinase activity. The first tyrosine kinase inhibitor (TKI) imatinib is claimed to have superior efficacy and side
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d73d914cf91345d9c471d4516fe6aa
http://europepmc.org/articles/PMC7249755
http://europepmc.org/articles/PMC7249755
Autor:
Hiroaki Kakutani, Hirokazu Tanaka, Shoko Nakayama, Shuji Minamoto, Shinya Rai, Yosaku Watatani, Itaru Matsumura, Yasuyoshi Morita, Yasuhiro Taniguchi, J. Luis Espinoza, Takahiro Kumode, Takashi Ashida
Publikováno v:
Leukemia Research Reports, Vol 14, Iss, Pp 100219-(2020)
Leukemia Research Reports
Leukemia Research Reports
We report a case with extramedullary tumors affecting the supraclavicular region that presented as a relapse of acute myeloid leukemia (AML) with FLT3-ITD mutation after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Treatment with g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8e0c38b8ddc8fc09f32416fcb2f7a3
http://www.sciencedirect.com/science/article/pii/S221304892030025X
http://www.sciencedirect.com/science/article/pii/S221304892030025X
Autor:
Yuki Miyazaki, Hiroto Kojima, Hiroh Saji, Hidenori Tanaka, Hiroshi Ureshino, Atsushi Kawaguchi, Takero Shindo, Shinya Kimura, Yasushi Kusunoki
Publikováno v:
Cancer Immunology Research. 6:745-754
Response to tyrosine kinase inhibitors (TKIs) is variable in chronic myeloid leukemia (CML), and elevated natural killer (NK) cells during TKI therapy are positively correlated with superior outcomes. NK cell function involves interactions of their k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e83bae5442eae6305dd52cb620a65f90
https://doi.org/10.1158/2326-6066.cir-17-0462
https://doi.org/10.1158/2326-6066.cir-17-0462